Tritoqualine (Inhibostamin)
(Synonyms: 酞茂异喹; Inhibostamin; Hypostamine) 目录号 : GC31833Tritoqualine (Inhibostamin) 用作组氨酸脱羧酶抑制剂。
Cas No.:14504-73-5
Sample solution is provided at 25 µL, 10mM.
Tritoqualine is used as a histidine decarboxylase inhibitor.
The effect of Tritoqualine (TRQ) on the CCl4-induced enzyme leakage is investigated by pretreatment of rats with Tritoqualine (200 mg/kg/day, p.o., 7 days). The ratio of lactate dehydrogenase (LDH) release from the cells of Tritoqualine-pretreated rats is significantly less than that in control rats. The rate of malondialdehyde (MDA) production is accelerated after the addition of 7.8 mM CCl4. Tritoqualine reduces its rate in a dose dependent manner, and it completely prevents CCl4-stimulated lipid peroxidation at a concentration of 33 μM[2].
A single administration of CCl4 (0.75 mL/kg, p.o.) causes a five-fold increase of in vivo lipid peroxidation in the liver. In contrast, a reduction of 37% in the lipid peroxidation is obtained by Tritoqualine (100 mg/kg) pretreatment for 14 days prior to CCl4 treatment. A 63% reduction is observed in vitamin E (25 mg/kg) pretreated rats[2].
[1]. Ishii K, et al. Therapeutic effect of histidine decarboxylase inhibitor on chronic active hepatitis. Gastroenterol Jpn. 1978;13(2):105-10. [2]. Yuasa S, et al. Suppressive effect of tritoqualine on lipid peroxidation and enzyme leakage induced by carbon tetrachloride in rat hepatocytes. Jpn J Pharmacol. 1986 Jun;41(2):205-10.
Kinase experiment: | Tritoqualine (TRQ) is suspended in 0.2% Tween 80 solution[2].Male Wistar rats weighing about 150 g are used. Tritoqualine (TRQ) is given to the rats (200 mg/kg, p.o.) daily for 7 days. Hepatocytes are isolated from a perfused liver by a modified Seglen's procedure. Briefly, perfusion of the liver is started with 150 mL of a 10 mM HEPES-buffered Ca2+ free Hanks' solution (pH 7.4) containing 0.5 mM EGTA. After 5 min, the liver is excised, and the perfusate is changed to 100 mL of a recirculating HEPES-buffered Hanks' solution (pH 7.4) containing 5 mM CaCl2, 0.05% collagenase and 0.005% soybean trypsin inhibitor instead of EGTA. The process continues for 15-20 min at 37°C with aeration of carbogen (95% O2, 5% CO2), until the liver began to disintegrate visibly. Cells are dispersed in a HEPES-buffered Hanks' solution (pH 7.4), filtered through a nylon stocking, and sedimented by triple centrifugation for 1 min at 50×g. Finally, the hepatocytes are suspended at 5×105 cells/mL in the same solution supplemented with 2% BSA. Two mL of the cell suspension is placed on 35 mm diameter culture dishes and incubated in an incubator at 37 °C. CCl4 is diluted with ethanol (10%, v/v) and added to the dishes at a concentration of 2.6 or 5.2 mM (0.25 or 0.5%, v/v, respectively). As a marker of cell membrane damage, lactate dehydrogenase (LDH) leaked out from the cells is determined using the supernatant of centrifuged samples. Total LDH activity is measured after lysis of the cells by sonication. The results are expressed as a ratio of LDH release induced by CCl4 to total LDH in the cells[2]. |
Animal experiment: | Rats[2] Tritoqualine (TRQ) is given p.o. to rats weighing about 200 g daily for 14 days. The same amount of 0.2% Tween 80 solution is given to the other rats. CCl4 diluted with olive oil (37.5%, v/v) is given to the rats (0.75 mL/kg, i.p.) 4 hr after the last administration of these compounds. The animals are killed 20 hr after the injection of CCl4. Serum is obtained from arterial blood. The liver is washed with 1.15% KCl solution through the portal vein, excised and homogenized in ten volumes of the same solution. Lipid peroxidation in the liver homogenates is quantified by the 1 % phosphoric acid method. All manipulations are done rapidly on ice to avoid further peroxidation. Glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) in the serum are measured using commercial test kits. |
References: [1]. Ishii K, et al. Therapeutic effect of histidine decarboxylase inhibitor on chronic active hepatitis. Gastroenterol Jpn. 1978;13(2):105-10. |
Cas No. | 14504-73-5 | SDF | |
别名 | 酞茂异喹; Inhibostamin; Hypostamine | ||
Canonical SMILES | O=C1OC(C2N(C)CCC3=C2C(OC)=C(OCO4)C4=C3)C5=C1C(N)=C(OCC)C(OCC)=C5OCC | ||
分子式 | C26H32N2O8 | 分子量 | 500.54 |
溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.9978 mL | 9.9892 mL | 19.9784 mL |
5 mM | 0.3996 mL | 1.9978 mL | 3.9957 mL |
10 mM | 0.1998 mL | 0.9989 mL | 1.9978 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet